Literature DB >> 21069488

The role of myocardial perfusion imaging in evaluating patients with myocardial bridging.

Kun Tang1, Ling Wang, Rongfang Shi, Xiangwu Zheng, Ting Li, Xiaobin Zhao, Ruming Lu.   

Abstract

BACKGROUND: Myocardial bridging (MB) is a common, congenital coronary-abnormality that is found on average in one out of every three adults at autopsy (Moehlenkamp et al in Circulation, 106:2616-2622, 2002; Erbel et al in Circulation, 120:357-359, 2009). However, its clinical significance and impact on myocardial ischemia remains controversial and unclear. Myocardial perfusion imaging (MPI) is widely used to assess myocardial ischemia in patients with known or suspected coronary artery disease, and is frequently performed to evaluate the hemodynamic significance of MB. This study was undertaken to determine the use of MPI in evaluating MB and to identify the characteristics of MB associated with perfusion defects using MPI. METHODS AND
RESULTS: Thirty-nine patients with MB of the left anterior descending (LAD) artery as documented by coronary angiography (CA) were enrolled for this study. None of the patients exhibited other forms of heart disease as determined by both CA and stress-rest MPI, no later than 1 month prior to the study. Using MPI, eight patients (20.5%) were found to have perfusion defects in the corresponding myocardial areas. This frequency was significantly higher when compared with results obtained by stress electrocardiogram. The difference in the mean systolic narrowing of bridging segments was statistically significant between patients with and without ischemia. The positive rate of reversible defects in patients with severe systolic narrowing was significantly higher than in patients with mild-to-moderate systolic narrowing. However, there was no significant difference either between the mean length of the tunneled artery in patients with and without abnormal MPI or the positive rate of abnormal MPI in patients with different locations of the tunneled artery.
CONCLUSIONS: MPI is an effective, noninvasive technique for the evaluation of patients with MB. The myocardial ischemia that resulted from bridging is associated more closely with the degree of systolic narrowing than with the length of tunneled artery or the location of MB.

Entities:  

Mesh:

Year:  2010        PMID: 21069488     DOI: 10.1007/s12350-010-9303-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  26 in total

1.  [Myocardial bridging as a cause of acute ischemia. Description of a case and review of the literature].

Authors:  M A Arnau Vives; L V Martínez Dolz; L Almenar Bonet; L A Lalaguna; F Ten Morro; M Palencia Pérez
Journal:  Rev Esp Cardiol       Date:  1999-06       Impact factor: 4.753

Review 2.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

3.  Myocardial bridging and milking effect of the left anterior descending coronary artery: normal variant or obstruction?

Authors:  J Noble; M G Bourassa; R Petitclerc; I Dyrda
Journal:  Am J Cardiol       Date:  1976-06       Impact factor: 2.778

4.  Functional, angiographic and intracoronary Doppler flow characteristics in symptomatic patients with myocardial bridging: effect of short-term intravenous beta-blocker medication.

Authors:  E R Schwarz; H G Klues; J vom Dahl; I Klein; W Krebs; P Hanrath
Journal:  J Am Coll Cardiol       Date:  1996-06       Impact factor: 24.094

Review 5.  Myocardial bridges: a review.

Authors:  P Angelini; M Trivellato; J Donis; R D Leachman
Journal:  Prog Cardiovasc Dis       Date:  1983 Jul-Aug       Impact factor: 8.194

6.  Clinical significance of isolated coronary bridges: benign and frequent condition involving the left anterior descending artery.

Authors:  J R Kramer; H Kitazume; W L Proudfit; F M Sones
Journal:  Am Heart J       Date:  1982-02       Impact factor: 4.749

7.  Myocardial perfusion SPECT imaging in patients with myocardial bridging.

Authors:  Enrique Vallejo; Mario Morales; Isabel Sánchez; Gustavo Sánchez; José Carlos Alburez; David Bialostozky
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

8.  Predictive value of dipyridamole thallium imaging in a patient with myocardial bridging but without fixed obstructive coronary artery disease.

Authors:  S M Rivitz; T Yasuda
Journal:  J Nucl Med       Date:  1992-10       Impact factor: 10.057

9.  Acute myocardial infarction in a young patient with myocardial bridge and elevated levels of free triiodothyronine.

Authors:  Salvatore Patanè; Filippo Marte; Francesco Patanè; Gianluca Di Bella; Sebastiano Chiofalo; Giuseppe Cinnirella; Rosario Evola
Journal:  Int J Cardiol       Date:  2007-11-26       Impact factor: 4.164

10.  Myocardial bridging in adult patients with hypertrophic cardiomyopathy.

Authors:  Paul Sorajja; Steve R Ommen; Rick A Nishimura; Bernard J Gersh; A Jamil Tajik; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2003-09-03       Impact factor: 24.094

View more
  3 in total

Review 1.  Myocardial Bridging: An Up-to-Date Review.

Authors:  Michael S Lee; Cheng-Han Chen
Journal:  J Invasive Cardiol       Date:  2015-05-15       Impact factor: 2.022

Review 2.  Anomalous Coronary Arteries: When to Follow-up, Risk Stratify, and Plan Intervention.

Authors:  Eduardo Leal Adam; Giuliano Generoso; Marcio Sommer Bittencourt
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

3.  Cardiovascular consequences of myocardial bridging: A meta-analysis and meta-regression.

Authors:  Sorin Hostiuc; Mugurel Constantin Rusu; Mihaela Hostiuc; Ruxandra Irina Negoi; Ionuț Negoi
Journal:  Sci Rep       Date:  2017-11-07       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.